Načítá se...

Clinical Study of the Use of the New Aminoglycoside Tobramycin for Therapy of Infections Due to Gram-Negative Bacteria

Tobramycin, a new aminoglycoside antimicrobial, was evaluated as therapy for infections due to gram-negative bacilli in 15 seriously ill patients with underlying diseases. Three of 10 patients with gram-negative bacteremias also had urinary tract infections. Two patients had respiratory tract infect...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jaffe, Gabriel, Ravreby, William, Meyers, Burt R., Hirschman, Shalom Z.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1974
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC428921/
https://ncbi.nlm.nih.gov/pubmed/4599125
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!